2 months ago
JNJ
AnalystsTim AndersonTim Anderson's Stock Forecasts
AnalystsTim Anderson
Sectors:
Industries:
Analyst Ranking
Top 28%
#1348 out of 4906 analysts
Average Return
+8.97%
Win Rate
78%14 out of 18
Risk vs Reward
Poor
Good
Tim Anderson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +35.75% | $41.51 | $26.67 | 2024-12-09 - 2025-06-13 | Sell |
Regeneron Pharmaceuticals IncREGN | +32.02% | $778.50 | $529.24 | 2024-12-09 - 2025-06-13 | Sell |
Abbvie IncABBV | +30.45% | $114.68 | $149.60 | 2021-05-02 - 2022-05-03 | Buy |
Aardvark Therapeutics IncAARD | +20.67% | $8.90 | $10.74 | 2025-03-26 - 2025-06-13 | Strong Buy |
Gilead Sciences IncGILD | +19.10% | $92.34 | $109.98 | 2024-12-09 - 2025-06-13 | Strong Buy |
Tim Anderson Analyst Color
Get additional color on Tim Anderson's coverage of popular stocks
3 months ago
GILD
4 months ago
MRK
5 months ago
JNJ
5 months ago
JNJ
6 months ago
PFE
6 months ago
LLY
Tim Anderson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 2 | Sell | $547.00 | +3.36% | Maintains | 2 months ago |
Johnson & JohnsonJNJ | 5 | Hold | $159.00 | +1.21% | Maintains | 2 months ago |
Aardvark Therapeutics IncAARD | 2 | Strong Buy | $26.00 | +142.09% | Maintains | 3 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $126.00 | +14.57% | Maintains | 3 months ago |
Amgen IncAMGN | 3 | Sell | $294.00 | -0.41% | Maintains | 3 months ago |
Abbvie IncABBV | 4 | Hold | $223.00 | +16.71% | Maintains | 3 months ago |
Metsera IncMTSR | 1 | Strong Buy | $38.00 | +29.34% | Initiates Coverage On | 4 months ago |
Moderna IncMRNA | 2 | Sell | $34.00 | +27.48% | Maintains | 4 months ago |
Merck & Co IncMRK | 4 | Strong Buy | $112.00 | +37.07% | Maintains | 4 months ago |
Pfizer IncPFE | 1 | Hold | $29.00 | +18.17% | Reinstates | 6 months ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $63.00 | +26.63% | Reinstates | 6 months ago |
Biogen IncBIIB | 1 | Hold | $178.00 | +36.24% | Reinstates | 6 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $997.00 | +21.68% | Reinstates | 6 months ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.